Nephrogenic Systemic Fibrosis
Nephrogenic systemic fibrosis, or NSF, is a relatively new disease that experts have linked to the use of gadolinium-based contrast agents—chemical dyes used prior to magnetic resonance imaging (MRI) to enhance results. The Food and Drug Administration first alerted the medical community and public about this link in June 2006, then again in December. In May 2007, the agency asked that the labeling of gadolinium-based MRI dyes be updated to include the risk of nephrogenic systemic fibrosis in patients with kidney disease or insufficiencies.
If you’ve been diagnosed with nephrogenic systemic fibrosis, you should consult with an experienced product liability attorney as soon as possible. Protect your legal rights by contacting us today to arrange a free consultation.
Makers of defective products deserve to be held accountable for the harm their products cause. By contacting a gadolinium attorney, individuals with nephrogenic systemic fibrosis may be able to hold the makers of gadolinium-based contrast agents responsible for their financial losses and emotional suffering. In cases where NSF results in death, family of the victim may be able to pursue damages on their loved one’s behalf. Recoverable damages often include:
- Medical bills and related expenses
- Mental anguish
- Pain and suffering
- Loss of companionship
- Lost income/earning capacity